LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice

LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice

<b>Background/Objectives:</b> Liver inflammatory diseases are a major global health burden and are often exacerbated by inflammation driven by lipopolysaccharides (LPS) through toll-like receptor 4 signaling. This study evaluates the anti-inflammatory effects of psilocybin and eugenol in...

Full description

Saved in:
Bibliographic Details
Main Authors: Gregory Ian Robinson, Marta Gerasymchuk, Timur Zanikov, Esmaeel Ghasemi Gojani, Shima Asghari, Alyssa Groves, Lucie Haselhorst, Sanjana Nandakumar, Cora Stahl, Ceejay Cruz, Mackenzie Cameron, Yeva Zahoruiko, Dongping Li, Rocio Rodriguez-Juarez, Alex Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Pharmaceuticals
Subjects:
psilocybin
eugenol
psychedelics
inflammation
lipopolysaccharide
liver
Online Access:https://www.mdpi.com/1424-8247/18/4/451
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items